Halozyme provides subcutaneous drug delivery solutions, with several major new products recently approved. Click here to find ...
The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for subcutaneous use for most previously approved adult, solid tumor Opdivo (nivolumab) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback